LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Затворен

СекторЗдравеопазване

12.04 -5.49

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

11.84

Максимум

12.62

Ключови измерители
By Trading Economics
Приходи	10M -33M
Продажби	-435K 54M
Марж на печалбата	-60.369
Служители	891
EBITDA	10M -31M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+86.44% upside

Дивиденти
By Dow Jones
Следващи печалби	6.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-686M 827M
Предишно отваряне	17.53
Предишно затваряне	12.04

Настроения в новините

By Acuity

54%

46%

286 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.02.2026 г., 22:04 ч. UTC

Печалби

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26.02.2026 г., 23:55 ч. UTC

Пазарно говорене

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26.02.2026 г., 23:40 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26.02.2026 г., 23:37 ч. UTC

Пазарно говорене

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26.02.2026 г., 23:32 ч. UTC

Печалби

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26.02.2026 г., 23:19 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26.02.2026 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26.02.2026 г., 23:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

26.02.2026 г., 23:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26.02.2026 г., 23:01 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26.02.2026 г., 22:55 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 22:43 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

26.02.2026 г., 22:43 ч. UTC

Пазарно говорене

RBA Hike In March Is Being Underpriced -- Market Talk

26.02.2026 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26.02.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26.02.2026 г., 22:13 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26.02.2026 г., 21:59 ч. UTC

Печалби

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26.02.2026 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

26.02.2026 г., 21:49 ч. UTC

Печалби

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26.02.2026 г., 21:45 ч. UTC

Печалби

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Expects Market to Remain Highly Competitive

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Says Supermarket Customers Remain Value Oriented

26.02.2026 г., 21:43 ч. UTC

Печалби

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26.02.2026 г., 21:43 ч. UTC

Печалби

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26.02.2026 г., 21:42 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26.02.2026 г., 21:41 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

86.44% нагоре

12-месечна прогноза

Среден 22 USD 86.44%

Висок 30 USD

Нисък 18 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

286 / 352 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.